The Rising Tide of Weight Reduction Therapies

Sabina Paglialunga, PhD Senior Director, Scientific Affairs Weight reduction drugs are making a big splash! Since glucagon-like peptide 1 (GLP-1) receptor agonists were first approved for weight loss in 2021, there has been an estimated 700% increase in prescriptions in the US.1 This has led to a wave of new GLP-1 and incretin products entering […] The post The Rising Tide of Weight Reduction Therapies first appeared on Celerion .